271 related articles for article (PubMed ID: 12821480)
1. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
Seral C; Van Bambeke F; Tulkens PM
Antimicrob Agents Chemother; 2003 Jul; 47(7):2283-92. PubMed ID: 12821480
[TBL] [Abstract][Full Text] [Related]
2. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
Carryn S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2002 Jul; 46(7):2095-103. PubMed ID: 12069960
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
Barcia-Macay M; Seral C; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2006 Mar; 50(3):841-51. PubMed ID: 16495241
[TBL] [Abstract][Full Text] [Related]
4. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
[TBL] [Abstract][Full Text] [Related]
5. Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.
Worlitzsch D; Kaygin H; Steinhuber A; Dalhoff A; Botzenhart K; Döring G
Antimicrob Agents Chemother; 2001 Jan; 45(1):196-202. PubMed ID: 11120965
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
[TBL] [Abstract][Full Text] [Related]
7. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
[TBL] [Abstract][Full Text] [Related]
8. Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
Belley A; Neesham-Grenon E; Arhin FF; McKay GA; Parr TR; Moeck G
Antimicrob Agents Chemother; 2008 Oct; 52(10):3820-2. PubMed ID: 18644953
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model.
Paillard D; Grellet J; Dubois V; Saux MC; Quentin C
Antimicrob Agents Chemother; 2002 Feb; 46(2):288-93. PubMed ID: 11796332
[TBL] [Abstract][Full Text] [Related]
10. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
11. Activities of antimicrobial agents against intracellular pneumococci.
Mandell GL; Coleman EJ
Antimicrob Agents Chemother; 2000 Sep; 44(9):2561-3. PubMed ID: 10952618
[TBL] [Abstract][Full Text] [Related]
12. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus.
Al-Nawas B; Shah PM
J Antimicrob Chemother; 1998 Jun; 41(6):655-8. PubMed ID: 9687105
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.
Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Denis O; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2012 Jul; 56(7):3700-11. PubMed ID: 22564838
[TBL] [Abstract][Full Text] [Related]
14. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
Seral C; Carryn S; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
[TBL] [Abstract][Full Text] [Related]
15. Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.
Kratzer C; Graninger W; Macfelda K; Buxbaum A; Georgopoulos A
Wien Klin Wochenschr; 2007; 119(9-10):297-302. PubMed ID: 17571234
[TBL] [Abstract][Full Text] [Related]
16. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.
Nguyen HA; Denis O; Vergison A; Theunis A; Tulkens PM; Struelens MJ; Van Bambeke F
Antimicrob Agents Chemother; 2009 Apr; 53(4):1434-42. PubMed ID: 19188393
[TBL] [Abstract][Full Text] [Related]
17. Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.
Van Bambeke F; Carryn S; Seral C; Chanteux H; Tyteca D; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2004 Aug; 48(8):2853-60. PubMed ID: 15273091
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.
Lismond A; Tulkens PM; Mingeot-Leclercq MP; Courvalin P; Van Bambeke F
Antimicrob Agents Chemother; 2008 Sep; 52(9):3040-6. PubMed ID: 18573933
[TBL] [Abstract][Full Text] [Related]
19. Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.
Carryn S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
J Antimicrob Chemother; 2003 Apr; 51(4):1051-2. PubMed ID: 12654747
[No Abstract] [Full Text] [Related]
20. Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus.
Lemaire S; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2011 Feb; 55(2):649-58. PubMed ID: 21135179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
